| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |